About one third of patients with esophageal cancer who have a compete response to neoadjuvant chemoradiotherapy may be able to avoid surgery. However, one expert questioned the study design.
Patients with nonerosive GERD do not have a greater risk for esophageal cancer compared with the general population and are unlikely to need additional endoscopic monitoring for cancer.
The risk of esophageal cancer was not decreased but rather increased among patients with Barrett esophagus who underwent anti-reflux surgery compared to medically managed peers in a large study.
New data reveal that vitamin D supplementation in a subgroup of patients with digestive tract cancer who are p53-immunoreactive may reduce their risk of relapse or death.